Patient Recruitment Outsourcing in emerging markets: the good, the bad, and the ugly

By Natalie Morrison

- Last updated on GMT

Companies outsourcing patient recruitment in emerging markets should have more people on the ground, according to Cutting Edge Information's Shaylyn Pike.

Pike, who is heads the emerging markets team at the pharmaceutical business research and decision support, joined us for a podcast as part of a series of interviews in the build-up to our Patient Recruitment Outsourcing conference this September.

She said: "I wouldn't say that outsourcing to emerging markets is a solution to all of the problems within the industry, but it is certainly piece of the puzzle that will balance it out."

For more information on patient recruitment, you can join us in Boston at our conference​, on September 26th & 27th.

Related news

Show more

Related products


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...


Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers